Piper Sandler is proposing a potential merger between e-commerce players eBay (NASDAQ:EBAY) and Etsy (NASDAQ:ETSY), citing complementary strengths that could address growth challenges and create a ...

Piper Sandler estimates potential EPS of $1.85 to $2.00, with the potential for 150-200 basis points of incremental margin for every $1 billion in additional sales. However, most SG&A leverage ...

Analysts at investment bank Piper Sandler (PIPR) are calling for a merger of e-commerce giants eBay (EBAY) and Etsy (ETSY), saying the economics of such a deal make sense. Easily identify stocks ...

Investing.com -- Piper Sandler assumed coverage of V.F. Corporation with a Neutral rating and a price target of $18, citing continued challenges in reviving growth at Vans, which remains a key factor ...

Piper Sandler is proposing a potential merger between e-commerce players eBay (NASDAQ:EBAY) and Etsy (NASDAQ:ETSY), citing complementary strengths that could address growth challenges and create a ...

Investing.com -- Piper Sandler assumed coverage of V.F. Corporation with a Neutral rating and a price target of $18, citing continued challenges in reviving growth at Vans, which remains a key fa ...

Investing.com -- Piper Sandler analysts maintained a positive stance on Microsoft (NASDAQ:MSFT) in a note Tuesday, despite recent weakness in its shares. The stock has dropped 11% over the past ...

Investing.com -- Piper Sandler analysts maintained a positive stance on Microsoft (NASDAQ:MSFT) in a note Tuesday, despite recent weakness in its shares. The stock has dropped 11% over the past three ...

Lowe’s Companies (NYSE:LOW – Free Report) had its target price decreased by Piper Sandler from $296.00 to $269.00 in a report issued on Monday morning,Benzinga reports. Piper Sandler currently ...

Freshpet (NASDAQ:FRPT – Free Report) had its price objective lowered by Piper Sandler from $160.00 to $145.00 in a research report report published on Tuesday morning,Benzinga reports.

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Nektar Therapeutics (NKTR – Research Report), with a price target of $7.00. The company’s shares closed ...